Clinical Trial Update: Insulin Secretory Defects in Pima Indians at High Risk for NIDDM

View source ↗

Summary

This clinical trial update notes the completion of a study examining insulin secretory defects in Pima Indians at high risk for Type 2 diabetes mellitus. The up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: NIDDM | Status: COMPLETED